Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to Clinical Candidate
Por um escritor misterioso
Descrição
Molecules, Free Full-Text
Targeting the RAS/RAF/MAPK pathway for cancer therapy: from
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead
Molecules, Free Full-Text
BIRB796 (Doramapimod) P38 MAPK inhibitor - Cellagen Technology
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead
Targeting the RAS/RAF/MAPK pathway for cancer therapy: from
Full article: A patent review of MAPK inhibitors (2018 – present)
The pyridazine heterocycle in molecular recognition and drug
Figure 2 from Switch control pocket inhibitors of p38-MAP kinase
1-(p-Tolyl)-3-tert-butyl-5-(3-phenylureido)-1H-pyrazole
de
por adulto (o preço varia de acordo com o tamanho do grupo)
